Evidence map›Paper›PMID 41706387›Full record

ArticleThe international journal of cardiovascular imaging2026

Cardiac magnetic resonance imaging for post-ablation lesion assessment and guiding re-ablation strategies in patients with paroxysmal atrial fibrillation : Role of CMR in AF recurrence post-ablation.

Sophie C Rier, Tommaso Semino, Giulia De Zan, Marco Guglielmo, Hemanth Ramanna, Jeroen F van der Heijden, Astrid A Hendriks, Maarten J Cramer, Pim van der Harst, Vincent J H M van Driel and 1 more

Abstract read
In one paragraph

Article in The international journal of cardiovascular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sophie C RierDepartment of Cardiology, Division of Heart and Lungs, Utrecht University, Utrecht University Medical Center, Utrecht, The Netherlands. s.rier@hagaziekenhuis.nl.ORCID http://orcid.org/0000-0001-5881-4937
Tommaso SeminoDepartment of Cardiology, Division of Heart and Lungs, Utrecht University, Utrecht University Medical Center, Utrecht, The Netherlands.
Giulia De ZanDepartment of Cardiology, Division of Heart and Lungs, Utrecht University, Utrecht University Medical Center, Utrecht, The Netherlands.
Marco GuglielmoDepartment of Cardiology, Division of Heart and Lungs, Utrecht University, Utrecht University Medical Center, Utrecht, The Netherlands.
Hemanth RamannaDepartment of Cardiology, Haga Teaching Hospital, Postbus 40551, Els Borst-Eilersplein 275, 2504 LN, The Hague, The Netherlands.
Jeroen F van der HeijdenDepartment of Cardiology, Haga Teaching Hospital, Postbus 40551, Els Borst-Eilersplein 275, 2504 LN, The Hague, The Netherlands.
Astrid A HendriksDepartment of Cardiology, Division of Heart and Lungs, Utrecht University, Utrecht University Medical Center, Utrecht, The Netherlands.
Maarten J CramerDepartment of Cardiology, Division of Heart and Lungs, Utrecht University, Utrecht University Medical Center, Utrecht, The Netherlands.
Pim van der HarstDepartment of Cardiology, Division of Heart and Lungs, Utrecht University, Utrecht University Medical Center, Utrecht, The Netherlands.
Vincent J H M van DrielDepartment of Cardiology, Haga Teaching Hospital, Postbus 40551, Els Borst-Eilersplein 275, 2504 LN, The Hague, The Netherlands.
Ivo A C van der BiltDepartment of Cardiology, Division of Heart and Lungs, Utrecht University, Utrecht University Medical Center, Utrecht, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atrial fibrillation (AF) recurrence after catheter ablation (CA), often due to incomplete lesions, remains a challenge. In this study, we evaluate the role of cardiac magnetic resonance (CMR) in characterizing lesion formation and guiding re-ablation strategies in patients with paroxysmal AF undergoing radiofrequency catheter ablation (RFCA). This prospective, single-center study enrolled patients undergoing first-time RFCA for paroxysmal AF. Pre-ablation CMR was performed for functional, anatomical, and fibrosis assessment. Repeat CMR 3 months post-ablation was performed to quantify fibrosis using Image Intensity Ratio (IIR) and detect lesion gaps, defined as ≥ 3 mm discontinuities in late gadolinium enhancement (LGE). AF recurrence was monitored for 18 months. 25 patients (20% female) were enrolled. 8/25 patients (32%) experienced AF recurrence. Post-ablation CMR showed significantly increased atrial fibrosis, though only in 2/25 patients (8%) complete circumferential pulmonary vein (PV) lesions were observed. Fibrosis burden did not differ significantly between patients with and without recurrence. Among 6 patients undergoing repeat ablation, 3 with LGE-defined gaps in circumferential lesions were successfully treated with a single re-isolation procedure. In contrast, 3 patients with extensive lesions and minimal or no gaps required multiple repeat procedures and additional ablation at extra-pulmonary vein sites. CMR can be a useful tool to assess post-ablation lesions and detect gaps after RFCA for paroxysmal AF. This may help distinguish recurrence due to insufficient initial ablation from other arrhythmogenic triggers, thereby guiding tailored and effective re-ablation strategies.

Indexed as

Atrial FibrillationCatheter AblationHeart AtriaMagnetic Resonance Imaging, CinePulmonary VeinsAgedContrast MediaFemaleFibrosisHeart RateHumansMaleMiddle AgedPredictive Value of TestsProspective StudiesRecurrenceContrast MediaArrhythmia recurrenceAtrial fibrillationAtrial fibrosisCardiac magnetic resonanceCatheter ablationPulmonary vein isolation

Identifiers

PMID41706387
PMCPMC13253590

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.